The Latest Cardiac and Vascular News
WALTHAM, Mass.–(BUSINESS WIRE)–Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication of new groundbreaking data reflecting the clinical impact of its flagship advanced preservation device, the Paragonix SherpaPak Cardiac Transport System (CTS), to protect and monitor donor hearts from extended criteria donors. In organ transplantation, an extended criteria donor is defined as having perceived risk factors linked to poor subsequent outcomes, for
IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Scott Ward has been appointed to the Endologix Board of Directors. Scott Ward was most recently the CEO and Chairman of the […]
First regulatory approval for the first-of-its-kind, fully-integrated PFA system with a simple and reproducible workflow Integrated with the world’s leading CARTO™ 3D cardiac mapping system for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AFib)…
SAN FRANCISCO, CA – JANUARY 8, 2024 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that the company has surpassed adoption in 1,500 hospitals in the United States, including the majority of the 50 largest healthcare systems. The company’s user base grew in 2023 by […]
2023 reported preliminary unaudited revenue in the range of approximately $1.255 billion – $1.259 billion, up approximately 9.0% – 9.4% year-over-year 2023 preliminary unaudited constant currency revenue* in the range of up approximately 9.6% – 9.9% year over year 2023 financial results and 2024 guidance to be released February 28, […]
SAN MATEO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio. The company offers a range of solutions […]
ALISO VIEJO, Calif., Jan. 8, 2024 /PRNewswire/ — Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention, today announced the appointment of Rhonda Robb as President and Chief…
ST. LOUIS, Jan. 08, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have been successfully treated using its Magnetic Interventional Ablation Catheter, MAGiC™. Stereotaxis’ MAGiC catheter is a robotically navigated magnetic ablation catheter designed to […]
Company’s award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures Company Builds Strong Foundation for Future Growth FORT LAUDERDALE, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or […]
CHARLESTOWN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors for an approximately $108.9 million […]
